Global Knee Hyaluronic Acid Injections Market

Knee Hyaluronic Acid Injections Comprehensive Study by Acid (Euflexxa, Hyalgan, Orthovisc, Monovisc, Supartz, Other), Sales Channel (Direct, Indirect), Dosage (Single Shot, Three-Five Shots), Solution (Solution, Gel) Players and Region - Global Market Outlook to 2030

Knee Hyaluronic Acid Injections Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Knee Hyaluronic Acid Injections
Knee Hyaluronic Acid Injections is used to treat knee pain caused by osteoarthritis in patients who were already treated with pain relievers and other treatments which did not work on pain. Osteoarthritis generally begins when cartilage breaks down in the knee and ultimately results in bone and joint damage. Which further creates pain even by simple movements like standing. The procedure of giving an injection is generally done under the guidance of a doctor and performed by an orthopedic physician. Sometimes, rheumatologists and primary care doctors also provide Knee Hyaluronic Acid Injections. This injection technique requires the high expertise of a trained medical professional. If by mistake the material is injected into any other area then the effectiveness and safety of the procedure will be reduced. With an increasing number of osteoarthritis patients, the demand for Knee Hyaluronic Acid Injections is increasing

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The Knee Hyaluronic Acid Injections market faces the biggest challenge of lack of trust among its users. There is a need for R&D investment to fully understand the benefits and side effects of the injection. Market leaders in the market account for most of the share due to a strong distribution network and reputation. There are no major barriers to entry in this market but high expertise is needed to operate in this market. Approval from regional health institutions is also necessary. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Allergan, Inc (Ireland), Galderma (Switzerland), Salix Pharmaceuticals (United States), Lifecore Biomedical (United States), Anika Therapeutics (United States), Sanofi (France), Shiseido (Japan), Smith and Nephew PLC. (United Kingdom) and LG Life Sciences (South Korea) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Maruha Nichiro Foods Inc. (Japan) and Fidia Pharma (Italy).

Segmentation Overview
AMA Research has segmented the market of Global Knee Hyaluronic Acid Injections market by and Region.



On the basis of geography, the market of Knee Hyaluronic Acid Injections has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Acid, the sub-segment i.e. Euflexxa will boost the Knee Hyaluronic Acid Injections market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Direct will boost the Knee Hyaluronic Acid Injections market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Dosage, the sub-segment i.e. Single Shot will boost the Knee Hyaluronic Acid Injections market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Solution, the sub-segment i.e. Solution will boost the Knee Hyaluronic Acid Injections market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Ineffectiveness of Traditional Non-Surgical Treatments Boosting the Demand for Knee Hyaluronic Acid Injections

Market Growth Drivers:
Growing Number of Osteoarthritis (OA) Patients and Increasing Age of Demographic in Developed Countries

Challenges:
Unclear Side-Effects of Knee Hyaluronic Acid Injections and Availability of Substitute Treatments of Knee Hyaluronic Acid Injections

Restraints:
Some Institutions Do Not Recommend Hyaluronic Injections Due to Lack of Evidence About Their Working

Opportunities:
Growing Research and Development in Measuring Effectiveness and New Technology in Knee Hyaluronic Acid Injections and Increasing Spending on Healthcare Infrastructure by Nations

Market Leaders and their expansionary development strategies

In May 2021, Ono Pharmaceutical Co., Ltd. and Seikagaku Corporation announced that Ono has launched JOYCLU 30mg Intra-articular Injection, a joint function improvement agent, for which Seikagaku received the manufacturing and marketing approval
In April 2019, the FDA of the US granted Fidia Pharms an Italian pharmaceutical firm approval for its hyaluronic acid injection called Triluron. This injection is designed to treat knee pain due to osteoarthritis. The mixture is primarily made of highly purified sodium hyaluronate which is derived from rooster comb and administered as an injection. This treatment is a course of three injections per week.

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Knee Hyaluronic Acid Injections Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Acid
  • Euflexxa
  • Hyalgan
  • Orthovisc
  • Monovisc
  • Supartz
  • Other

By Sales Channel
  • Direct
  • Indirect

By Dosage
  • Single Shot
  • Three-Five Shots

By Solution
  • Solution
  • Gel

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Osteoarthritis (OA) Patients
      • 3.2.2. Increasing Age of Demographic in Developed Countries
    • 3.3. Market Challenges
      • 3.3.1. Unclear Side-Effects of Knee Hyaluronic Acid Injections
      • 3.3.2. Availability of Substitute Treatments of Knee Hyaluronic Acid Injections
    • 3.4. Market Trends
      • 3.4.1. Ineffectiveness of Traditional Non-Surgical Treatments Boosting the Demand for Knee Hyaluronic Acid Injections
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Knee Hyaluronic Acid Injections, by Acid, Sales Channel, Dosage, Solution and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Knee Hyaluronic Acid Injections (Value)
      • 5.2.1. Global Knee Hyaluronic Acid Injections by: Acid (Value)
        • 5.2.1.1. Euflexxa
        • 5.2.1.2. Hyalgan
        • 5.2.1.3. Orthovisc
        • 5.2.1.4. Monovisc
        • 5.2.1.5. Supartz
        • 5.2.1.6. Other
      • 5.2.2. Global Knee Hyaluronic Acid Injections by: Sales Channel (Value)
        • 5.2.2.1. Direct
        • 5.2.2.2. Indirect
      • 5.2.3. Global Knee Hyaluronic Acid Injections by: Dosage (Value)
        • 5.2.3.1. Single Shot
        • 5.2.3.2. Three-Five Shots
      • 5.2.4. Global Knee Hyaluronic Acid Injections by: Solution (Value)
        • 5.2.4.1. Solution
        • 5.2.4.2. Gel
      • 5.2.5. Global Knee Hyaluronic Acid Injections Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Knee Hyaluronic Acid Injections: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan, Inc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Galderma (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Salix Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Lifecore Biomedical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Anika Therapeutics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shiseido (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith and Nephew PLC. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LG Life Sciences (South Korea)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Knee Hyaluronic Acid Injections Sale, by Acid, Sales Channel, Dosage, Solution and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Knee Hyaluronic Acid Injections (Value)
      • 7.2.1. Global Knee Hyaluronic Acid Injections by: Acid (Value)
        • 7.2.1.1. Euflexxa
        • 7.2.1.2. Hyalgan
        • 7.2.1.3. Orthovisc
        • 7.2.1.4. Monovisc
        • 7.2.1.5. Supartz
        • 7.2.1.6. Other
      • 7.2.2. Global Knee Hyaluronic Acid Injections by: Sales Channel (Value)
        • 7.2.2.1. Direct
        • 7.2.2.2. Indirect
      • 7.2.3. Global Knee Hyaluronic Acid Injections by: Dosage (Value)
        • 7.2.3.1. Single Shot
        • 7.2.3.2. Three-Five Shots
      • 7.2.4. Global Knee Hyaluronic Acid Injections by: Solution (Value)
        • 7.2.4.1. Solution
        • 7.2.4.2. Gel
      • 7.2.5. Global Knee Hyaluronic Acid Injections Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Knee Hyaluronic Acid Injections: by Acid(USD Million)
  • Table 2. Knee Hyaluronic Acid Injections Euflexxa , by Region USD Million (2018-2023)
  • Table 3. Knee Hyaluronic Acid Injections Hyalgan , by Region USD Million (2018-2023)
  • Table 4. Knee Hyaluronic Acid Injections Orthovisc , by Region USD Million (2018-2023)
  • Table 5. Knee Hyaluronic Acid Injections Monovisc , by Region USD Million (2018-2023)
  • Table 6. Knee Hyaluronic Acid Injections Supartz , by Region USD Million (2018-2023)
  • Table 7. Knee Hyaluronic Acid Injections Other , by Region USD Million (2018-2023)
  • Table 8. Knee Hyaluronic Acid Injections: by Sales Channel(USD Million)
  • Table 9. Knee Hyaluronic Acid Injections Direct , by Region USD Million (2018-2023)
  • Table 10. Knee Hyaluronic Acid Injections Indirect , by Region USD Million (2018-2023)
  • Table 11. Knee Hyaluronic Acid Injections: by Dosage(USD Million)
  • Table 12. Knee Hyaluronic Acid Injections Single Shot , by Region USD Million (2018-2023)
  • Table 13. Knee Hyaluronic Acid Injections Three-Five Shots , by Region USD Million (2018-2023)
  • Table 14. Knee Hyaluronic Acid Injections: by Solution(USD Million)
  • Table 15. Knee Hyaluronic Acid Injections Solution , by Region USD Million (2018-2023)
  • Table 16. Knee Hyaluronic Acid Injections Gel , by Region USD Million (2018-2023)
  • Table 17. South America Knee Hyaluronic Acid Injections, by Country USD Million (2018-2023)
  • Table 18. South America Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 19. South America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 20. South America Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 21. South America Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 22. Brazil Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 23. Brazil Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 24. Brazil Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 25. Brazil Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 26. Argentina Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 27. Argentina Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 28. Argentina Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 29. Argentina Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 30. Rest of South America Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 31. Rest of South America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 32. Rest of South America Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 33. Rest of South America Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 34. Asia Pacific Knee Hyaluronic Acid Injections, by Country USD Million (2018-2023)
  • Table 35. Asia Pacific Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 36. Asia Pacific Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 37. Asia Pacific Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 38. Asia Pacific Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 39. China Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 40. China Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 41. China Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 42. China Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 43. Japan Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 44. Japan Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 45. Japan Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 46. Japan Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 47. India Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 48. India Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 49. India Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 50. India Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 51. South Korea Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 52. South Korea Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 53. South Korea Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 54. South Korea Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 55. Taiwan Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 56. Taiwan Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 57. Taiwan Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 58. Taiwan Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 59. Australia Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 60. Australia Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 61. Australia Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 62. Australia Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 67. Europe Knee Hyaluronic Acid Injections, by Country USD Million (2018-2023)
  • Table 68. Europe Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 69. Europe Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 70. Europe Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 71. Europe Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 72. Germany Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 73. Germany Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 74. Germany Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 75. Germany Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 76. France Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 77. France Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 78. France Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 79. France Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 80. Italy Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 81. Italy Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 82. Italy Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 83. Italy Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 84. United Kingdom Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 85. United Kingdom Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 86. United Kingdom Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 87. United Kingdom Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 88. Netherlands Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 89. Netherlands Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 90. Netherlands Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 91. Netherlands Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 92. Rest of Europe Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 93. Rest of Europe Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 94. Rest of Europe Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 95. Rest of Europe Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 96. MEA Knee Hyaluronic Acid Injections, by Country USD Million (2018-2023)
  • Table 97. MEA Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 98. MEA Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 99. MEA Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 100. MEA Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 101. Middle East Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 102. Middle East Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 103. Middle East Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 104. Middle East Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 105. Africa Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 106. Africa Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 107. Africa Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 108. Africa Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 109. North America Knee Hyaluronic Acid Injections, by Country USD Million (2018-2023)
  • Table 110. North America Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 111. North America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 112. North America Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 113. North America Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 114. United States Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 115. United States Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 116. United States Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 117. United States Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 118. Canada Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 119. Canada Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 120. Canada Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 121. Canada Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 122. Mexico Knee Hyaluronic Acid Injections, by Acid USD Million (2018-2023)
  • Table 123. Mexico Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2018-2023)
  • Table 124. Mexico Knee Hyaluronic Acid Injections, by Dosage USD Million (2018-2023)
  • Table 125. Mexico Knee Hyaluronic Acid Injections, by Solution USD Million (2018-2023)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Knee Hyaluronic Acid Injections: by Acid(USD Million)
  • Table 136. Knee Hyaluronic Acid Injections Euflexxa , by Region USD Million (2025-2030)
  • Table 137. Knee Hyaluronic Acid Injections Hyalgan , by Region USD Million (2025-2030)
  • Table 138. Knee Hyaluronic Acid Injections Orthovisc , by Region USD Million (2025-2030)
  • Table 139. Knee Hyaluronic Acid Injections Monovisc , by Region USD Million (2025-2030)
  • Table 140. Knee Hyaluronic Acid Injections Supartz , by Region USD Million (2025-2030)
  • Table 141. Knee Hyaluronic Acid Injections Other , by Region USD Million (2025-2030)
  • Table 142. Knee Hyaluronic Acid Injections: by Sales Channel(USD Million)
  • Table 143. Knee Hyaluronic Acid Injections Direct , by Region USD Million (2025-2030)
  • Table 144. Knee Hyaluronic Acid Injections Indirect , by Region USD Million (2025-2030)
  • Table 145. Knee Hyaluronic Acid Injections: by Dosage(USD Million)
  • Table 146. Knee Hyaluronic Acid Injections Single Shot , by Region USD Million (2025-2030)
  • Table 147. Knee Hyaluronic Acid Injections Three-Five Shots , by Region USD Million (2025-2030)
  • Table 148. Knee Hyaluronic Acid Injections: by Solution(USD Million)
  • Table 149. Knee Hyaluronic Acid Injections Solution , by Region USD Million (2025-2030)
  • Table 150. Knee Hyaluronic Acid Injections Gel , by Region USD Million (2025-2030)
  • Table 151. South America Knee Hyaluronic Acid Injections, by Country USD Million (2025-2030)
  • Table 152. South America Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 153. South America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 154. South America Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 155. South America Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 156. Brazil Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 157. Brazil Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 158. Brazil Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 159. Brazil Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 160. Argentina Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 161. Argentina Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 162. Argentina Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 163. Argentina Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 164. Rest of South America Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 165. Rest of South America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 166. Rest of South America Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 167. Rest of South America Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 168. Asia Pacific Knee Hyaluronic Acid Injections, by Country USD Million (2025-2030)
  • Table 169. Asia Pacific Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 170. Asia Pacific Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 171. Asia Pacific Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 172. Asia Pacific Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 173. China Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 174. China Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 175. China Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 176. China Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 177. Japan Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 178. Japan Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 179. Japan Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 180. Japan Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 181. India Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 182. India Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 183. India Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 184. India Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 185. South Korea Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 186. South Korea Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 187. South Korea Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 188. South Korea Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 189. Taiwan Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 190. Taiwan Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 191. Taiwan Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 192. Taiwan Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 193. Australia Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 194. Australia Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 195. Australia Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 196. Australia Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 197. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 198. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 201. Europe Knee Hyaluronic Acid Injections, by Country USD Million (2025-2030)
  • Table 202. Europe Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 203. Europe Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 204. Europe Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 205. Europe Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 206. Germany Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 207. Germany Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 208. Germany Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 209. Germany Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 210. France Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 211. France Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 212. France Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 213. France Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 214. Italy Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 215. Italy Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 216. Italy Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 217. Italy Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 218. United Kingdom Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 219. United Kingdom Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 220. United Kingdom Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 221. United Kingdom Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 222. Netherlands Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 223. Netherlands Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 224. Netherlands Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 225. Netherlands Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 226. Rest of Europe Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 227. Rest of Europe Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 228. Rest of Europe Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 229. Rest of Europe Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 230. MEA Knee Hyaluronic Acid Injections, by Country USD Million (2025-2030)
  • Table 231. MEA Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 232. MEA Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 233. MEA Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 234. MEA Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 235. Middle East Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 236. Middle East Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 237. Middle East Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 238. Middle East Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 239. Africa Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 240. Africa Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 241. Africa Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 242. Africa Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 243. North America Knee Hyaluronic Acid Injections, by Country USD Million (2025-2030)
  • Table 244. North America Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 245. North America Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 246. North America Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 247. North America Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 248. United States Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 249. United States Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 250. United States Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 251. United States Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 252. Canada Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 253. Canada Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 254. Canada Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 255. Canada Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 256. Mexico Knee Hyaluronic Acid Injections, by Acid USD Million (2025-2030)
  • Table 257. Mexico Knee Hyaluronic Acid Injections, by Sales Channel USD Million (2025-2030)
  • Table 258. Mexico Knee Hyaluronic Acid Injections, by Dosage USD Million (2025-2030)
  • Table 259. Mexico Knee Hyaluronic Acid Injections, by Solution USD Million (2025-2030)
  • Table 260. Research Programs/Design for This Report
  • Table 261. Key Data Information from Secondary Sources
  • Table 262. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Knee Hyaluronic Acid Injections: by Acid USD Million (2018-2023)
  • Figure 5. Global Knee Hyaluronic Acid Injections: by Sales Channel USD Million (2018-2023)
  • Figure 6. Global Knee Hyaluronic Acid Injections: by Dosage USD Million (2018-2023)
  • Figure 7. Global Knee Hyaluronic Acid Injections: by Solution USD Million (2018-2023)
  • Figure 8. South America Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 9. Asia Pacific Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 10. Europe Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 11. MEA Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 12. North America Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 13. Global Knee Hyaluronic Acid Injections share by Players 2023 (%)
  • Figure 14. Global Knee Hyaluronic Acid Injections share by Players (Top 3) 2023(%)
  • Figure 15. Global Knee Hyaluronic Acid Injections share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Allergan, Inc (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Allergan, Inc (Ireland) Revenue: by Geography 2023
  • Figure 19. Galderma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Galderma (Switzerland) Revenue: by Geography 2023
  • Figure 21. Salix Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 22. Salix Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 23. Lifecore Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 24. Lifecore Biomedical (United States) Revenue: by Geography 2023
  • Figure 25. Anika Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 26. Anika Therapeutics (United States) Revenue: by Geography 2023
  • Figure 27. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi (France) Revenue: by Geography 2023
  • Figure 29. Shiseido (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Shiseido (Japan) Revenue: by Geography 2023
  • Figure 31. Smith and Nephew PLC. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Smith and Nephew PLC. (United Kingdom) Revenue: by Geography 2023
  • Figure 33. LG Life Sciences (South Korea) Revenue, Net Income and Gross profit
  • Figure 34. LG Life Sciences (South Korea) Revenue: by Geography 2023
  • Figure 35. Global Knee Hyaluronic Acid Injections: by Acid USD Million (2025-2030)
  • Figure 36. Global Knee Hyaluronic Acid Injections: by Sales Channel USD Million (2025-2030)
  • Figure 37. Global Knee Hyaluronic Acid Injections: by Dosage USD Million (2025-2030)
  • Figure 38. Global Knee Hyaluronic Acid Injections: by Solution USD Million (2025-2030)
  • Figure 39. South America Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 40. Asia Pacific Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 41. Europe Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 42. MEA Knee Hyaluronic Acid Injections Share (%), by Country
  • Figure 43. North America Knee Hyaluronic Acid Injections Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergan, Inc (Ireland)
  • Galderma (Switzerland)
  • Salix Pharmaceuticals (United States)
  • Lifecore Biomedical (United States)
  • Anika Therapeutics (United States)
  • Sanofi (France)
  • Shiseido (Japan)
  • Smith and Nephew PLC. (United Kingdom)
  • LG Life Sciences (South Korea)
Additional players considered in the study are as follows:
Maruha Nichiro Foods Inc. (Japan) , Fidia Pharma (Italy)
Select User Access Type

Key Highlights of Report


Mar 2024 250 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Knee Hyaluronic Acid Injections Market Quantitative research analysis
Global Knee Hyaluronic Acid Injections Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Allergan, Inc (Ireland), Galderma (Switzerland), Salix Pharmaceuticals (United States), Lifecore Biomedical (United States), Anika Therapeutics (United States), Sanofi (France), Shiseido (Japan), Smith and Nephew PLC. (United Kingdom) and LG Life Sciences (South Korea) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Ineffectiveness of Traditional Non-Surgical Treatments Boosting the Demand for Knee Hyaluronic Acid Injections" is seen as one of major influencing trends for Knee Hyaluronic Acid Injections Market during projected period 2023-2030.
The Knee Hyaluronic Acid Injections market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Knee Hyaluronic Acid Injections Market Report?

Have a Query? Click Here

Other Related Reports

Venous Skin Ulcer Treatment Comprehensive Study by Type (Compression Therapy, Advanced Wound Dressings, Negative Pressure Wound Therapy, Skin Grafts & Substitutes, Medications, Others), Application (...
$ 3750
MET Inhibitor Drugs Comprehensive Study by Type (C-Met Biological Inhibitors, Small Molecule C-Met Inhibitors, C-Met Antagonist Antibodies, HGF Antagonist Antibodies, Kringle Variant Antagonists), Di...
$ 3650
Kennel Cough Treatment Comprehensive Study by Application (Mild Cases, Secondary Infection), Drug Type (Baytril, Doxycycline, Clavamox, Others), Route of Administration (Oral, Injectable, Intra-nasal...
$ 3450
Antiviral Drugs Treatment Comprehensive Study by Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System Modulators), Application (Hepatitis, HIV/AIDS, Herpes, I...
$ 3500
Fish Free Omega 3 Comprehensive Study by Type (Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)), Application (Dietary Supplements, Pharma and Personal, Animal Feed...
$ 3750
Triamterene Tablets Comprehensive Study by Application (Hospital, Retail Pharmacies, Other), End Use (Metabolic or Respiratory Acidosis, Acute Myopia & Secondary Angle-Closure Glaucoma), Packaging (B...
$ 3350